JP2022528278A5 - - Google Patents

Info

Publication number
JP2022528278A5
JP2022528278A5 JP2021560412A JP2021560412A JP2022528278A5 JP 2022528278 A5 JP2022528278 A5 JP 2022528278A5 JP 2021560412 A JP2021560412 A JP 2021560412A JP 2021560412 A JP2021560412 A JP 2021560412A JP 2022528278 A5 JP2022528278 A5 JP 2022528278A5
Authority
JP
Japan
Prior art keywords
cancer
combinations
group
cpt1a
ifng
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021560412A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022528278A (ja
JP7782835B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2020/004602 external-priority patent/WO2020204674A2/ko
Publication of JP2022528278A publication Critical patent/JP2022528278A/ja
Publication of JP2022528278A5 publication Critical patent/JP2022528278A5/ja
Priority to JP2025179760A priority Critical patent/JP2026021394A/ja
Application granted granted Critical
Publication of JP7782835B2 publication Critical patent/JP7782835B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021560412A 2019-04-05 2020-04-03 Ｃｆｄｎａを用いたがん診断方法 Active JP7782835B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025179760A JP2026021394A (ja) 2019-04-05 2025-10-24 Ｃｆｄｎａを用いたがん診断方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR20190039974 2019-04-05
KR10-2019-0039974 2019-04-05
KR20190157368 2019-11-29
KR10-2019-0157368 2019-11-29
PCT/KR2020/004602 WO2020204674A2 (ko) 2019-04-05 2020-04-03 Cfdna를 이용한 암 진단방법

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025179760A Division JP2026021394A (ja) 2019-04-05 2025-10-24 Ｃｆｄｎａを用いたがん診断方法

Publications (3)

Publication Number Publication Date
JP2022528278A JP2022528278A (ja) 2022-06-09
JP2022528278A5 true JP2022528278A5 (enExample) 2023-04-11
JP7782835B2 JP7782835B2 (ja) 2025-12-09

Family

ID=72666861

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021560412A Active JP7782835B2 (ja) 2019-04-05 2020-04-03 Ｃｆｄｎａを用いたがん診断方法
JP2025179760A Pending JP2026021394A (ja) 2019-04-05 2025-10-24 Ｃｆｄｎａを用いたがん診断方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025179760A Pending JP2026021394A (ja) 2019-04-05 2025-10-24 Ｃｆｄｎａを用いたがん診断方法

Country Status (7)

Country Link
US (1) US20220170108A1 (enExample)
EP (1) EP3950962A4 (enExample)
JP (2) JP7782835B2 (enExample)
KR (10) KR102526906B1 (enExample)
CN (1) CN113677808A (enExample)
TW (1) TW202104598A (enExample)
WO (1) WO2020204674A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2627085B (en) 2019-11-06 2024-11-13 Univ Leland Stanford Junior Methods and systems for analysing nucleic acid molecules
WO2022203093A1 (ko) * 2021-03-22 2022-09-29 이원다이애그노믹스(주) 암 발생여부를 진단 또는 예측하는 방법
US11783912B2 (en) 2021-05-05 2023-10-10 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for analyzing nucleic acid molecules
CN113718031B (zh) * 2021-08-17 2022-05-20 浙江大学医学院附属妇产科医院 一种卵巢癌早期诊断组合物的建立
CN116219012A (zh) * 2022-12-15 2023-06-06 华中科技大学同济医学院附属同济医院 基于血浆cfDNA片段分布特征预测宫颈癌新辅助化疗效果或复发高危分类的系统及方法
KR20250030880A (ko) 2023-08-25 2025-03-05 경상국립대학교병원 폐암 치료 예후 예측을 위한 정보제공방법 및 폐암 치료 예후 예측용 조성물
KR20250074714A (ko) * 2023-11-15 2025-05-28 주식회사 진캐스트 Rna를 이용한 폐암 변이 유전자의 대규모 다중 검출 방법 및 이를 이용한 폐암 변이 유전자의 대규모 다중 검출 키트
WO2025127193A1 (ko) * 2023-12-13 2025-06-19 연세대학교 산학협력단 높은 sfrp4의 발현을 보이는 암의 치료방법
WO2025213150A1 (en) * 2024-04-06 2025-10-09 Precede Biosciences, Inc. Methods, kits and systems for measuring psa and psma expression and methods for treating cancer based on same
CN118497344A (zh) * 2024-05-11 2024-08-16 青岛可立生物医药有限公司 用于结直肠癌诊断及分型的生物标志物及筛选方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070044048A (ko) * 2004-08-11 2007-04-26 더 클리브랜드 클리닉 파운데이션 갑상선암의 검출방법
US9315802B2 (en) * 2009-12-30 2016-04-19 Quest Diagnostics Investments Incorporated RNA isolation from soluble urine fractions
EP3218523B1 (en) * 2014-11-14 2020-02-12 Liquid Genomics Inc. Use of circulating cell-free rna for diagnosis and/or monitoring cancer
WO2016145323A1 (en) * 2015-03-11 2016-09-15 The Governing Council Of The University Of Toronto An electrochemical clamp assay
MA45480A (fr) * 2015-03-12 2018-01-17 Janssen Pharmaceutica Nv Marqueurs d'arnm à base de sang total pour prédire un cancer de la prostate, et leurs procédés de détection
KR101751962B1 (ko) 2015-04-30 2017-06-30 주식회사 넥스바이오 세포-유리형 dna의 위암 진단 용도
KR101701618B1 (ko) * 2015-06-23 2017-02-13 국립암센터 전도성 고분자를 이용한 세포 유리 ｄｎａ 검출용 구조체 및 이의 용도
US11149299B2 (en) * 2015-06-25 2021-10-19 Ramesh Vallabhaneni Method and system for multiplex profiling of chromosomes in biological samples using target-specific DNA probes
KR20170124683A (ko) * 2016-05-02 2017-11-13 연세대학교 산학협력단 담도암 진단용 신규 바이오마커로서의 융합 유전자 및 융합 단백질
KR101925125B1 (ko) 2016-06-16 2018-12-04 울산대학교 산학협력단 Nckap1을 유효성분으로 포함하는 대장암 진단 또는 대장암 전이 예후 예측용 바이오마커 조성물
KR101818352B1 (ko) * 2016-06-30 2018-01-15 충북대학교 산학협력단 방광암의 진단 및 예후 예측용 바이오 마커 및 그의 용도
KR101980819B1 (ko) * 2016-12-23 2019-05-21 주식회사 제놉시 자성 나노 입자가 탑재된 전도성 고분자 및 양이온성 고분자를 포함하는 세포-유리(cell-free) DNA 검출 및 회수용 자성 나노 구조체
US10870891B2 (en) * 2017-01-05 2020-12-22 Biodesix, Inc. Diagnostic test system for specific, sensitive and reproducible detection of circulating nucleic acids in whole blood
KR20200003917A (ko) * 2017-05-10 2020-01-10 난토믹스, 엘엘씨 암의 검출, 예측, 및 모니터링을 위한 순환 rna(circulating rna for detection, prediction, and monitoring of cancer)
CN107164543A (zh) 2017-06-16 2017-09-15 上海长海医院 Kras 作为胰腺癌中生物标志物的用途
JP2021526029A (ja) * 2018-06-01 2021-09-30 ジェノプシー・カンパニー・リミテッドＧｅｎｏｐｓｙ Ｃｏ．， Ｌｔｄ． 不安定セルフリーｄｎａを検出する方法およびそれを使用するデバイス

Similar Documents

Publication Publication Date Title
JP2022528278A5 (enExample)
KR102526913B1 (ko) Cfdna를 이용한 대장암 진단방법
ES2491222T3 (es) Marcadores de expresión génica para el pronóstico de cáncer colorrectal
US10179936B2 (en) Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy
CA2762082C (en) Markers for detection of gastric cancer
JP7540765B2 (ja) 直腸がんの術前化学放射線標準治療反応予測および治療後の予後予測のための組成物および標準治療後の予後が非常に悪い患者を予測する方法および組成物
US10132811B2 (en) Salivary transcriptomic and microbial biomarkers for pancreatic cancer
US9702009B2 (en) Urine gene expression ratios for detection of cancer
ES2714582T3 (es) Procedimiento de predicción de la respuesta a la quimioterapia en un paciente que padece o está en riesgo de desarrollar un cáncer de mama recurrente
Lee et al. Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas
CN107541563B (zh) 一种用于早期诊断、预测脓毒血症并发急性肾损伤的分子标记物、试剂盒及应用
CN110229899B (zh) 用于结直肠癌早期诊断或预后预测的血浆标记物组合
KR102194215B1 (ko) 위암 진단용 바이오마커 및 이의 용도
Kalmár et al. Gene-expression analysis of a colorectal cancer-specific discriminatory transcript set on formalin-fixed, paraffin-embedded (FFPE) tissue samples
CN116219007A (zh) 检测结直肠癌的生物标志物组及其应用
NZ577012A (en) Human zymogen granule protein 16 as a marker for detection of gastric cancer